Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China

Figure 2

The presence of DR from 13 individuals with DR strains. PI: protease inhibitor; NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; ATV: atazanavir; DRV: darunavir; FPV: fosamprenavir; IDV: indinavir; LPV: lopinavir; NFV: nelfinavir; SQV: saquinavir; TPV: tipranavir/r; 3TC: lamivudine;ABC: abacavir;AZT: zidovudine;D4T: stavudine;DDI: didanosine;FTC: emtricitabine;TDF: tenofovir;EFV:efavirenz; ETR: etravirine;NVP:nevirapine;RPV:rilpivirine.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us